BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling.

Signal Transduct Target Ther · 2024 · PMC11609275 · PMID 39617757

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Generally, the extent of pERK elevation correlates with the level of RAS signaling activity during erythropoiesis, showing a decreasing trend from CD71 − CD235a − to CD71 + CD235a + cells.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.